Experiment summary for ENCSR000DSB
doi:10.17989/ENCSR000DSB
Summary
- Status
- released
- Assay
- ChIP-seq (Control ChIP-seq)
- Control type
- input library
- Biosample summary
- Homo sapiens cardiovascular progenitor cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 5 days, 10 ng/mL Bone morphogenetic protein 4 for 5 days, 6 ng/mL Activin A for 5 days
- Biosample Type
- in vitro differentiated cells
- Replication type
- unreplicated
- Description
- Control ChIP-seq on human H7-hESC differentiated 5 days
- Treatments
- 5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 5 days, 10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 5 days, 6 ng/mL Activin A (CHEBI:81351) for 5 days
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
- Platform
- Illumina Genome Analyzer
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG004592 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- Date submitted
- June 25, 2011
- Date released
- February 16, 2012
- Reference Epigenome
- ENCSR689KKY
- Treatment Time Series
- ENCSR831IZS , ENCSR114LRH , ENCSR182ORV
- Submitter comment
- Replicate 1,1 of this experiment was previously attributed to biosample ENCBS296AAA but it has since been corrected to the current biosample. Please note that the biosample term has remain unchanged.
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 1 | 1 | Homo sapiens female embryo cardiovascular progenitor in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 5 days, 10 ng/mL Bone morphogenetic protein 4 for 5 days, 6 ng/mL Activin A for 5 days | ENCBS360WQQ | ENCLB243OTZ |